Published on 12/2/2021 in the Prospect News Structured Products Daily.
New Issue: GS Finance sells $612,000 autocallable underlier-linked notes on Russell, Nasdaq, Biotech ETF
By Kiku Steinfeld
Chicago, Dec. 2 – GS Finance Corp. priced $612,000 of 0% autocallable underlier-linked notes due Aug. 19, 2024 linked to the Russell 2000 index, the Nasdaq-100 index and the SPDR S&P Biotech ETF, according to a 424B2 with the Securities and Exchange Commission.
The notes are guaranteed by Goldman Sachs Group, Inc.
The notes will be automatically called at par plus a 15% annualized call premium if the least performing underlier closes at or above its initial level on any quarterly evaluation date after six months.
If the least performing underlier finishes at or above its initial level, the payout at maturity will be par plus 45%.
If the worst performer falls by up to 30%, the payout will be par. Otherwise, investors will be exposed to the worst performer’s decline from its initial level.
Goldman Sachs & Co. LLC is the underwriter.
Issuer: | GS Finance Corp.
|
Guarantor: | Goldman Sachs Group, Inc.
|
Issue: | Autocallable underlier-linked notes
|
Underlying assets: | Russell 2000 index, Nasdaq-100 index and SPDR S&P Biotech ETF
|
Amount: | $612,000
|
Maturity: | Aug. 19, 2024
|
Coupon: | 0%
|
Price: | Par
|
Payout at maturity: | If the least performing underlier finishes at or above initial level, par plus 45%; if the worst performer declines by up to 30%, par; otherwise, investors will be fully exposed to the worst performer’s decline from its initial level
|
Call: | Automatically at par plus a 15% annualized call premium if least performing underlier closes at or above initial level on any quarterly evaluation date after six months
|
Initial levels: | 15,027.76 for Nasdaq, 2,250.343 for Russell, $125.66 for Biotech
|
Trigger buffer levels: | 70% of initial levels
|
Pricing date: | Aug. 11
|
Settlement date: | Aug. 16
|
Underwriter: | Goldman Sachs & Co. LLC
|
Fees: | 0.95%
|
Cusip: | 40057J7B6
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.